Christopher Yea, Chief Development Officer: KalVista Pharmaceuticals KALV Sell · Filed 23/02/23

Trade details

Type: Insider sale
Amount: $20,888.82
Shares · price: 2,727 sh · $7.66 a share
Held after: 35,709 sh
Stock: KalVista Pharmaceuticals KALV
Person: Christopher YeaChief Development Officer
Trade date: 23/02/17
Filed: 23/02/23
Days to filing: 6 days

Sold 7.1% of holdings

Share of holding sold: 7.1%

KalVista Pharmaceuticals trades, last 26 weeks

What else happened in KalVista Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/01/18~23/03/19

Christopher Yea's recent trades

Christopher YeaChief Development Officer
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$905.2K
33,800 sh
$905.2K
Filed 05/29
Traded 05/27
Christopher YeaChief Development Officer
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$52.6K
1,966 sh
$52.6K
Filed 05/27
Traded 05/26
Christopher YeaChief Development Officer
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$63.1K
2,358 sh
$63.1K
Filed 05/26
Traded 05/22
Christopher YeaChief Development Officer
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$29.7K
1,108 sh
$29.7K
Filed 05/19
Traded 05/18
Christopher YeaChief Development Officer
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$67.7K
4,347 sh
$67.7K
Filed 02/24
Traded 02/23